- 靶点:
- CD42d
- 简介:
- >>ECM-receptor interaction;>>Platelet activation;>>Hematopoietic cell lineage
- 基因名称:
- GP5
- 蛋白名称:
- Platelet glycoprotein V
- Human Gene Id:
- 2814
- Human Swiss Prot No:
- P40197
- Mouse Swiss Prot No:
- O08742
- Rat Gene Id:
- 25259
- Rat Swiss Prot No:
- O08770
- 免疫原:
- The antiserum was produced against synthesized peptide derived from the Internal region of human GP5. AA range:331-380
- 特异性:
- CD42d Polyclonal Antibody detects endogenous levels of CD42d protein.
- 组成:
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 来源:
- Polyclonal, Rabbit,IgG
- 稀释:
- WB 1:500 - 1:2000. IHC: 1:100-1:300. ELISA: 1:10000.. IF 1:50-200
- 纯化工艺:
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- 浓度:
- 1 mg/ml
- 储存:
- -15°C to -25°C/1 year(Do not lower than -25°C)
- 其他名称:
- GP5;Platelet glycoprotein V;GPV;Glycoprotein 5;CD42d
- 实测条带:
- 62kD
- 背景:
- Human platelet glycoprotein V (GP5) is a part of the Ib-V-IX system of surface glycoproteins that constitute the receptor for von Willebrand factor (VWF; MIM 613160) and mediate the adhesion of platelets to injured vascular surfaces in the arterial circulation, a critical initiating event in hemostasis. The main portion of the receptor is a heterodimer composed of 2 polypeptide chains, an alpha chain (GP1BA; MIM 606672) and a beta chain (GP1BB; MIM 138720), that are linked by disulfide bonds. The complete receptor complex includes noncovalent association of the alpha and beta subunits with platelet glycoprotein IX (GP9; MIM 173515) and GP5. Mutations in GP1BA, GP1BB, and GP9 have been shown to cause Bernard-Soulier syndrome (MIM 231200), a bleeding disorder (review by Lopez et al., 1998 [PubMed 9616133]).[supplied by OMIM, Nov 2010],
- 功能:
- function:The GPIb-V-IX complex functions as the vWF receptor and mediates vWF-dependent platelet adhesion to blood vessels. The adhesion of platelets to injured vascular surfaces in the arterial circulation is a critical initiating event in hemostasis.,PTM:The N-terminus is blocked.,similarity:Contains 14 LRR (leucine-rich) repeats.,tissue specificity:Platelets and megakaryocytes.,
- 细胞定位:
- Membrane; Single-pass type I membrane protein.
- 组织表达:
- Platelets and megakaryocytes.
Enhanced Proliferation of Visualizable Mesenchymal Stem Cell–Platelet Hybrid Cell for Versatile Intracerebral Hemorrhage Treatment ACS Nano Dai-Wen Pang WB,IF,FC Mouse platelets (PLs),mesenchymal stem cells (MSCs),fusion cells(FCs)
货号:YT5587
Enhanced Proliferation of Visualizable Mesenchymal Stem Cell–Platelet Hybrid Cell for Versatile Intracerebral Hemorrhage Treatment ACS Nano Dai-Wen Pang WB,IF,FC Mouse platelets (PLs),mesenchymal stem cells (MSCs),fusion cells(FCs)
货号:YT5587
- June 19-2018
- WESTERN IMMUNOBLOTTING PROTOCOL
- June 19-2018
- IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
- June 19-2018
- IMMUNOFLUORESCENCE PROTOCOL
- September 08-2020
- FLOW-CYTOMEYRT-PROTOCOL
- May 20-2022
- Cell-Based ELISA│解您多样本WB检测之困扰
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
- July 13-2018
- Antibody-FAQs
- 产品图片
- Enhanced Proliferation of Visualizable Mesenchymal Stem Cell–Platelet Hybrid Cell for Versatile Intracerebral Hemorrhage Treatment ACS Nano Dai-Wen Pang WB,IF,FC Mouse platelets (PLs),mesenchymal stem cells (MSCs),fusion cells(FCs)
- Enhanced Proliferation of Visualizable Mesenchymal Stem Cell–Platelet Hybrid Cell for Versatile Intracerebral Hemorrhage Treatment ACS Nano Dai-Wen Pang WB,IF,FC Mouse platelets (PLs),mesenchymal stem cells (MSCs),fusion cells(FCs)
- Western Blot analysis of Hela cells using CD42d Polyclonal Antibody. Secondary antibody(catalog#:RS0002) was diluted at 1:20000
- Immunohistochemical analysis of paraffin-embedded human-tonsils, antibody was diluted at 1:100